Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients

Area of Science:

• Immunology
• Autoimmunity
• Dermatology

Background:

• Systemic sclerosis (SSc) is an autoimmune disease with complex pathogenesis.
• The immune system, particularly T and B cell interactions, is implicated in SSc.
• Semaphorin 4D (CD100) and CD72 are key molecules in T and B cell cooperation and have been linked to autoimmunity.

Purpose of the Study:

• To investigate the expression levels of CD100 and CD72 on T and B cells in patients with SSc.
• To determine the potential role of CD100 and CD72 dysregulation in the pathogenesis of SSc.

Main Methods:

• Flow cytometry was used to analyze CD100 and CD72 expression on T and B cells.
• Serum levels of soluble CD100 were measured in SSc patients and healthy donors.
• Correlations between CD100/CD72 expression and clinical parameters of SSc were assessed.

Main Results:

• Systemic sclerosis patients exhibited increased percentages of CD100(high) T and B cells.
• Significantly elevated CD100 expression was observed on CD4(+) T cells in SSc.
• Soluble CD100 levels were frequently detected in the sera of SSc patients.
• CD100 dysregulations correlated with anti-Scl70 antibodies, disease type, skin thickening, disease duration, and inflammation.

Conclusions:

• Dysregulation of CD100 expression and release may contribute to the development and/or progression of systemic sclerosis.
• CD100's role in T and B cell cooperation highlights its potential involvement in SSc pathogenesis.
• Further research into CD100 pathways could offer new therapeutic targets for SSc.